Helmerich & Payne Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Helmerich & Payne Inc. Common Stock trades at $38.46 (market cap $3.91B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.8× Helmerich & Payne Inc. Common Stock's market cap, and Helmerich & Payne Inc. Common Stock pays the higher dividend (2.56%). Which is the better fit depends on your goals — on Pluang, investors hold Helmerich & Payne Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| HP | RDY | |
|---|---|---|
Market Cap | $3.91B | $10.78B |
Volume | 800,382 | 2,724,343 |
Sector | Energy | Health |
52-Week High | $47.64 | $15.38 |
52-Week Low | $23.11 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.54B | $10.68B |
Dividend Yield | 2.56% | 0.65% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.
Read more on HP →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →